Jaime Altamirano, MD
Cardiovascular Disease · Palmetto Bay, FLNPI 1346290863
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Curium US LLC at 49.5% of the total. Reporting peaked in 2023 at $155 and has fallen 75.4% since, to $38 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in FL, where the typical reported total is $2,774.
Across 9 payments — averaging $28.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Curium US LLC$125
- Astellas Pharma US Inc$40
- Biotronik Inc.$21
- E.r. Squibb & Sons, L.L.C.$19
- Kestra Medical Technology Services, Inc.$18
- GE HealthCare$16
- plus $14 from 1 others
What the payments were for
- Food & beverage$253100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Curium US LLC | 1 | $125 |
| Astellas Pharma US Inc | 2 | $40 |
| Biotronik Inc. | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Kestra Medical Technology Services, Inc. | 1 | $18 |
| GE HealthCare | 2 | $16 |
| Asahi Intecc USA, Inc. | 1 | $14 |
How this compares
$253 in reported general payments places this provider in the 10th percentile of 1,740 cardiovascular disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 42 | $32,884 |
| XareltoRivaroxaban | 25 | $30,980 |
| BrilintaTicagrelor | 11 | $13,142 |
| FarxigaDapagliflozin Propanediol | 18 | $10,198 |
| Repatha SureclickEvolocumab | 12 | $6,952 |
| Nifedipine ErNifedipine | 56 | $2,017 |
| Rosuvastatin Calcium | 40 | $1,537 |
| Labetalol Hcl | 42 | $1,526 |
| Digoxin | 26 | $887 |
| Losartan Potassium | 52 | $653 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 44 | $630 |
| Metoprolol Tartrate | 42 | $465 |
| Atorvastatin Calcium | 23 | $457 |
| Amlodipine Besylate | 47 | $378 |
| Olmesartan Medoxomil | 18 | $368 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Palmetto Bay
- Kevin MakatiLutz$1.6M
- Hiram BezerraTampa$698K
- William OneillNaples$637K
- Theodore FeldmanMiami$637K
- John Gerald CantoLakeland$588K
- Alan MillerJacksonville$547K
- Seth BaumBoca Raton$517K
- Elliott EliasMiami$497K
- Vijay HaryaniVero Beach$413K
- Neel PatelMaitland$392K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.